BCOR and mesenchymal cell neoplasm: Pathogenic alterations of BCOR have been reported in various tumor types including HGNET-BCOR-ITD, CNS tumor with BCOR/BCOR(L1)-fusion, endometrial stromal and soft tissue sarcomas, primitive myxoid mesenchymal tumors of infancy and undifferentiated round cell sarcoma.